Across TCGA pan-cancer cohorts, PICSAR RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated PICSAR data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PICSAR RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PICSAR expression acts as an unfavorable survival marker, although some lineages such as ESCA and READ show a favorable association.
KIRP, LIHC, and LUAD are the cancer types where PICSAR RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.